Parent Terms |
Term With Siblings |
Child Terms |
|
(2R,3S,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-3-oxolanol
(2S)-2-amino-N-[(2S,3S,4R)-5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
(R)-DRF053 hydrochloride hydrate
1,N6-Ethenodeoxyadenosine
2-(3,4-dimethoxyphenyl)-9-[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]purine-6-carboxamide
2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide
2-Amino-9-[4-hydroxy-2-(hydroxymethyl)butyl]-3H-purin-6-one
2-amino-9-pentyl-3H-purine-6-thione
2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
2-amino-N-[5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
3,7-dihydropurine-6-thione
3-(3-Methylbut-2-en-1-yl)-3H-purin-6-amine
4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide
4-(2,6-difluorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide
4-[1-methyl-6-oxo-3-(phenylmethyl)-2-sulfanylidene-7H-purin-8-yl]butanoic acid
4-[[9-[(3R)-3-oxolanyl]-8-(2,4,6-trifluoroanilino)-2-purinyl]amino]-1-cyclohexanol
5-(4-methoxyphenyl)-6-sulfanylidene-1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
5′-(3′′-deoxy-beta-D-ribofuranosyl)-3′-deoxyadenosine
6,7-Dihydro-3H-purine-2,6-diamine
6-\{4-[4-(4-chlorophenyl)piperidin-4-yl]phenyl\}-9H-purine
7-(trimethylsilyl)-2,6-bis[(trimethylsilyl)oxy]-7H-purine
9-(2-oxolanyl)-3H-purine-6-thione
9-cyclopentyl-3H-purine-6-thione
9-cyclopentyl-N(8)-(2-fluorophenyl)-N(2)-(4-methoxyphenyl)-9H-purine-2,8-diamine
[(4aR,5R,6R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphinin-5-yl] butanoate
benzoic acid [5-(6-benzamido-9-purinyl)-3-fluoro-4-hydroxy-2-oxolanyl]methyl ester
bohemine Purine substituted on C-2, C-6 and N-9 with (3-hydroxypropyl)amino, benzylamino and isopropyl groups respectively; a synthetic, cell-permeable, cyclin-dependent kinase (CDK) inhibitor that is structurally similar to olomoucine and roscovitine.
butanoic acid [(4aS,5R,6R,7aR)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
methyl purine-6-carboxylate
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)piperidine-4-carboxamide
N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide
N-\{[(5-\{6-[(\{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy\}(hydroxy)phosphoryl)amino]-9H-purin-9-yl\}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl\}-2,3-dihydroxy-4-methylpentanimidic acid
N-purin-6-oyl-epsilon-aminocaproic acid
purine nucleoside bisphosphate +
|
|
|
Synonyms |
Exact Synonyms: |
3-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}propan-1-ol
|
Related Synonyms: |
2-[(3-hydroxypropyl)amino]-6-benzylamino-9-isopropylpurine
;
3-{[6-(benzylamino)-9-isopropyl-9H-purin-2-yl]amino}propan-1-ol
;
Formula=C18H24N6O
;
InChI=1S/C18H24N6O/c1-13(2)24-12-21-15-16(20-11-14-7-4-3-5-8-14)22-18(23-17(15)24)19-9-6-10-25/h3-5,7-8,12-13,25H,6,9-11H2,1-2H3,(H2,19,20,22,23)
;
InChIKey=OPQGFIAVPSXOBO-UHFFFAOYSA-N
;
SMILES=CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc12
|
Xref Mesh: |
MESH:C118034
|
Xrefs: |
PMID:11181503
;
PMID:12487731
;
PMID:12667701
;
PMID:19003322
;
PMID:22250642
;
PMID:24675180
;
PMID:26024233
;
Reaxys:8716256 |
|